Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy-Reference-Cited by-同舟云学术

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

Published:2008 Issue:6 Volume:59 Page:785-793
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Keystone E.,Burmester G. R.,Furie R.,Loveless J. E.,Emery P.,Kremer J.,Tak P. P.,Broder M. S.,Yu E.,Cravets M.,Magrini F.,Jost F.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.23715/fullpdf

Reference50 articles.

1. Epidemiology of rheumatic diseases

2. Rheumatoid Arthritis—A Molecular Understanding

3. THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS

4. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

5. Do self‐perpetuating B lymphocytes drive human autoimmune disease?

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study;Rheumatology and Therapy;2024-03-11

2. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases;RMD Open;2023-12

3. Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis;Advances in Rheumatology;2023-07-06

4. Meta‐Analyses on the Effects of Disease‐Modifying Antirheumatic Drugs on the Most Relevant Patient‐Reported Outcome Domains in Rheumatoid Arthritis;Arthritis Care & Research;2023-02-22

5. Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study;Annals of Hematology;2022-07-23